Lemelson MIT prize awarded to drug delivery inventor DeSimone: related news

Lemelson-MIT prize awarded to drug delivery inventor DeSimone

MIT has awarded its prestigious Lemelson-MIT $500,000 prize to Joseph DeSimone for his research developments in drug delivery, medical devices and green manufacturing.

Sngle-walled carbon nanotubes used as cancer drug delivery vehicles

Add our medical news to StumbleUpon - Sngle-walled carbon nanotubes used as cancer drug delivery vehicles Add our medical news to Facebook - Sngle-walled carbon nanotubes used as cancer drug delivery vehicles

MIT sues Affymetrix for patent infringement

Affymetrix, the Santa Clara maker of tools used to study DNA and diagnose diseases, was sued for patent infringement by the Massachusetts Institute of Technology over the company's GeneChip system used to analyze genes. Affymetrix has knowingly infringed the patent, MIT and a company started by an MIT professor said in a federal court complaint filed Tuesday in Boston. Affymetrix filed an application with the U.S. Patent and Trademark Office in September 2004, six months after a similar patent was approved for MIT, the university said in its complaint. The patent regulators ruled in May 2007 that the MIT group was the first inventor, according to the complaint. The GeneChip technology is used to develop new therapeutic drugs and to investigate the cause of cancer, AIDS and other diseases, Affymetrix has said.

Novatel Wireless Awarded Patent for Message Delivery System to Communicate with Multimode Mobile Internet Devices

Novatel Wireless Awarded Patent for Message Delivery System to Communicate with Multimode Mobile Internet Devices

Novatel Wireless Awarded Patent for Message Delivery System to

Novatel Wireless Awarded Patent for Message Delivery System to Communicate with Multimode Mobile Internet Devices

Nanogate AG awarded international prize by NASA Dotfarm-Optics receives the Nano 50 Award

Home > Press > Nanogate AG awarded international prize by NASA Dotfarm®-Optics receives the Nano 50 Award

SurModics Inc licenses nanotechnology drug delivery system from PharmaSol GmbH

SurModics Inc (Nasdaq:SRDX), a provider of surface modification and drug delivery technologies to the healthcare industry, reported on 14 July that the company's subsidiary, Brookwood Pharmaceuticals has acquired the license to lipid nanoparticle technology from PharmaSol GmbH of Berlin, Germany.

SurModics Inc licenses nanotechnology drug delivery system from PharmaSol GmbH

SurModics Inc (Nasdaq:SRDX), a provider of surface modification and drug delivery technologies to the healthcare industry, reported on 14 July that the company's subsidiary, Brookwood Pharmaceuticals has acquired the license to lipid nanoparticle technology from PharmaSol GmbH of Berlin, Germany.

SurModics Inc licenses nanotechnology drug delivery system from PharmaSol GmbH

SurModics Inc (Nasdaq:SRDX), a provider of surface modification and drug delivery technologies to the healthcare industry, reported on 14 July that the company's subsidiary, Brookwood Pharmaceuticals has acquired the license to lipid nanoparticle technology from PharmaSol GmbH of Berlin, Germany.

SurModics and Brookwood License Nanotechnology Drug Delivery System

SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that its Brookwood Pharmaceuticals subsidiary has licensed lipid nanoparticle technology from PharmaSol GmbH of Berlin, Germany. Under the agreement, Brookwood has exclusive rights to all pharmaceutical applications of the technology.

SurModics and Brookwood License Nanotechnology Drug Delivery System

SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that its Brookwood Pharmaceuticals subsidiary has licensed lipid nanoparticle technology from PharmaSol GmbH of Berlin, Germany. Under the agreement, Brookwood has exclusive rights to all pharmaceutical applications of the technology.

SurModics and Brookwood License Nanotechnology Drug Delivery System

EDEN PRAIRIE, Minn. - (Business Wire) SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that its Brookwood Pharmaceuticals subsidiary has licensed lipid nanoparticle technology from PharmaSol GmbH of Berlin, Germany. Under the agreement, Brookwood has exclusive rights to all pharmaceutical applications of the technology.

SurModics and Brookwood License Nanotechnology Drug Delivery System

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jul 14, 2008 - SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that its Brookwood Pharmaceuticals subsidiary has licensed lipid nanoparticle technology from PharmaSol GmbH of Berlin, Germany. Under the agreement, Brookwood has exclusive rights to all pharmaceutical applications of the technology.

Drug Halts Decline In Alzheimer's Patients

ljw1004 writes "Alzheimer's researchers are divided on whether the disease is caused by 'beta amyloid' (a peptide found in Alzheimer brains) or by 'tau protein' (normally used for cellular scaffolding, but can aggregate out of control and destroy neurons). Today in Chicago a new drug has been announced that stops tau aggregation and appears to have halted Alzheimer's-related decline in 300 clinical trial patients. The drug is known as 'rember.' Do you have friends or family who appear to be on the road to dementia? Here is an online questionnaire, part of one used in the clinical trial to diagnose dementia. (Disclosure: I made the online questionnaire, and my father is one of the scientists behind the drug.)"

Nanotech Revives a Cancer Drug

Special delivery: This blood-vessel cell--the same type of cell that feeds spreading tumors--has absorbed a newly formulated cancer drug. In this fluorescence image, the cell’s structural elements are labeled red, the nucleus is labeled blue, and a cancer drug encased in a polymer envelope is labeled green.

DestinationRx Launches Drug Trends Today Blog

LOS ANGELES & CHICAGO - (Business Wire) DestinationRx today announced the launch of its new blog site, www.drugtrendstoday.com, which will serve as a vehicle for sharing data and trends related to the prescription drug industry. As a leader in drug comparison and purchasing technology, DestinationRx is in a unique position to provide readers with valuable and relevant information on the ever-changing drug market.

DestinationRx Launches Drug Trends Today Blog

LOS ANGELES & CHICAGO--(BUSINESS WIRE)--Jul 17, 2008 - DestinationRx today announced the launch of its new blog site, www.drugtrendstoday.com, which will serve as a vehicle for sharing data and trends related to the prescription drug industry. As a leader in drug comparison and purchasing technology, DestinationRx is in a unique position to provide readers with valuable and relevant information on the ever-changing drug market.

DestinationRx Launches Drug Trends Today Blog

LOS ANGELES & CHICAGO--(BUSINESS WIRE)--July 17, 2008--DestinationRx today announced the launch of its new blog site, www.drugtrendstoday.com, which will serve as a vehicle for sharing data and trends related to the prescription drug industry. As a leader in drug comparison and purchasing technology, DestinationRx is in a unique position to provide readers with valuable and relevant information on the ever-changing drug market.

Mastercam X2 Certified for Inventor 2009

CAD/CAM software, has announced that its Mastercam X2 package has been certified for Autodesk Inventor 2009 CAD software by the Autodesk Inventor Certified Applications Programme. To be certified, a product must meet certain guidelines and demonstrate a high level of quality as well as compatibility with Autodesk Inventor. Certification follows testing and approval.

Inventor swoops for Haydock prize

Inventor came with a late run to deny long-time leader Laterly in the Bet365 Best Odds Handicap at Haydock.

Natural art prize awarded (ABC)

Michael McWilliams won the Waterhouse Natural History art prize for his painting 'Bandicoot Playground'.

Madonna, Carla Bruni, Spike Lee

'Midnight's Children," by Salman Rushdie , won the "Best of the Booker" prize on Thursday to mark the 40th anniversary of one of the most prestigious literary awards in the world. The work won the Booker Prize in 1981. The award Thursday was decided by the public from a short list of six authors in an online poll. Rushdie, whose 1988 novel "The Satanic Verses" outraged many Muslims and prompted death threats against him, also won the 25th anniversary Booker prize in 1993. "I think it was an extraordinary short list and it was an honor to be on it," Rushdie said in a recorded message from the United States, where he is on a book tour. His sons, Zafar and Milan , accepted a trophy in London on his behalf. The other nominees included the Nobel Prize winners J.

Search took 0.09 seconds.